This list will certainly increase in the future for signaling via TLR3, TLR7/8, and TLR9, promote Th1 responses, and various synthetic TLR ligands have been created, several of which have been shown to have antitumor effects in clinical trials in different types of cancer. The gene discussed is TLR3; the disease is cancer.